A nurse is caring for a patient diagnosed with placental accreta who is being prepared for a cesarean hysterectomy. The patient is exhibiting signs of anxiety and her vital signs show tachycardia and hypotension. Which nursing intervention is the priority at this time?

B) Administer ordered IV fluids to stabilize the patient's blood pressure.

A) Provide emotional support to the patient and her partner to alleviate anxiety.

B) Administer ordered IV fluids to stabilize the patient's blood pressure.

C) Educate the patient about the surgical procedure to reduce her anxiety.

D) Prepare the surgical site and ensure all surgical consents are signed.

A patient with a diagnosis of placental accreta is being prepared for a cesarean hysterectomy due to severe hemorrhage risk. Which nursing intervention is the highest priority to ensure the patient's safety during the preoperative period?

C) Establishing and maintaining two large-bore IV lines for potential transfusions.

A) Administering prophylactic antibiotics as ordered to prevent infection.

B) Ensuring the patient has signed informed consent for the procedure.

C) Establishing and maintaining two large-bore IV lines for potential transfusions.

D) Providing emotional support to reduce the patient's anxiety levels.

A patient with suspected placental accreta is experiencing worsening hemodynamic instability and altered level of consciousness preoperatively. Which of the following interventions is most critical for the nurse to prioritize at this time?

B) Preparing and administering a bolus of intravenous crystalloids to support circulatory volume

A) Administering supplemental oxygen to maintain oxygen saturation above 92%

B) Preparing and administering a bolus of intravenous crystalloids to support circulatory volume

C) Initiating continuous cardiac monitoring to detect arrhythmias

D) Educating the patient and family about the upcoming procedure and potential outcomes

A patient in the operating room is experiencing significant vaginal bleeding and signs of hemodynamic instability. Which nursing intervention is most appropriate to prioritize before the surgery begins?

B) Administer a rapid bolus of intravenous crystalloids as ordered by the physician.

A) Increase the patient's supplemental oxygen to 100% via non-rebreather mask.

B) Administer a rapid bolus of intravenous crystalloids as ordered by the physician.

C) Position the patient in a Trendelenburg position to improve cerebral perfusion.

D) Initiate a blood transfusion immediately without waiting for cross-matching.

A patient undergoing surgery for placental accreta with suspected percreta is experiencing significant hemorrhage, metabolic acidosis, and hemodynamic instability. Which nursing intervention is the priority at this time to stabilize the patient's condition?

C) Administering vasopressors to maintain adequate blood pressure.

A) Administering additional crystalloid fluids to increase blood volume.

B) Preparing the patient for potential hysterectomy to control bleeding.

C) Administering vasopressors to maintain adequate blood pressure.

D) Increasing ventilatory support to improve oxygen saturation.

During a surgical procedure for severe placental accreta with suspected percreta, the patient exhibits signs of hemodynamic instability, including hypotension, tachycardia, and metabolic acidosis. Which nursing intervention is the highest priority to stabilize the patient?

A) Administering additional crystalloids to improve blood volume.

B) Initiating vasopressor therapy to maintain adequate blood pressure.

C) Increasing ventilatory support to improve oxygen saturation.

A patient undergoing massive transfusion protocol develops a right-sided pleural effusion and metabolic acidosis. After a therapeutic thoracentesis, oxygen saturation improves, but hemodynamic instability persists. Which nursing intervention is most appropriate to address the patient's current condition?

D) Prepare for the administration of cryoprecipitate to address coagulopathy

A) Administer intravenous diuretics to manage fluid overload

B) Initiate vasopressor therapy to stabilize blood pressure

C) Increase ventilatory support to improve oxygenation

D) Prepare for the administration of cryoprecipitate to address coagulopathy

A patient who underwent a massive transfusion protocol now presents with a right-sided pleural effusion and metabolic acidosis. After thoracentesis, her respiratory status improves, but her hemodynamic status remains unstable with hypotension and tachycardia. Which intervention should the nurse anticipate next to address her coagulopathy and potential for disseminated intravascular coagulation (DIC)?

B) Prepare for administration of cryoprecipitate to support coagulation.

A) Administer intravenous fluids to improve blood pressure.

B) Prepare for administration of cryoprecipitate to support coagulation.

C) Increase ventilatory support to manage respiratory acidosis.

D) Monitor urine output to assess for renal failure.

A patient with a history of placental accreta has developed hemoperitoneum and is suspected of having disseminated intravascular coagulation (DIC). After the administration of cryoprecipitate, which of the following nursing assessments would be most critical to perform next to evaluate the effectiveness of this intervention?

C) Checking the patient's fibrinogen levels

A) Monitoring the patient's urine output

B) Assessing the patient's respiratory rate

C) Checking the patient's fibrinogen levels

D) Evaluating the patient's level of consciousness

A patient with a history of placental accreta and recent surgery is experiencing hemodynamic instability with increasing abdominal distension and tenderness. An ultrasound reveals hemoperitoneum, and laboratory findings indicate a prolonged prothrombin time and low fibrinogen level, suggesting disseminated intravascular coagulation (DIC). After administering cryoprecipitate, which of the following nursing interventions is most critical to implement next?

A) Monitor the patient's urine output every hour.

B) Administer intravenous fluids to maintain blood pressure.

C) Prepare the patient for immediate transfer to the operating room.

D) Assess the patient's mental status and level of consciousness.

placental accreta - Nursing Case Study

Pathophysiology

• Primary mechanism: Placental accreta occurs when the placenta attaches too deeply into the uterine wall due to a defective decidua basalis, the layer that usually prevents excessive invasion beyond the endometrium. This defect often happens in areas of previous uterine trauma, like cesarean scars.

• Secondary mechanism: Abnormal trophoblastic invasion is another critical factor. In placental accreta, cytotrophoblasts invade beyond normal limits, embedding into the myometrium, which can cause insufficient separation at delivery.

• Key complication: This abnormal attachment can lead to severe postpartum hemorrhage during attempted placental separation, posing significant risks for maternal morbidity and necessitating surgical intervention.

Patient Profile

Demographics:

32-year-old female, teacher

History:

• Key past medical history: Previous cesarean section, hypertension

• Current medications: Labetalol, prenatal vitamins

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Vaginal bleeding in the third trimester

• Key symptoms: Abdominal pain, fatigue, dizziness

• Vital signs: Blood pressure 140/90 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

During the initial assessment, the healthcare team notes that the patient is experiencing increased vaginal bleeding and escalating abdominal pain. On examination, her abdomen is tender to palpation, particularly in the lower quadrants, and the uterine fundus is firm but tender. The patient's vital signs indicate increasing instability: her blood pressure has dropped to 130/85 mmHg, her heart rate has risen to 120 bpm, and she reports feeling more fatigued and lightheaded. Her skin is pale and slightly clammy, suggesting compromised perfusion. A bedside ultrasound reveals that the placenta has invaded the myometrium with no clear plane of separation, consistent with a diagnosis of placental accreta.

The medical team orders a complete blood count (CBC) and coagulation profile to assess for anemia and potential coagulopathy due to the ongoing blood loss. Results show a hemoglobin level of 8.5 g/dL, indicating significant anemia, and a platelet count of 95,000/uL, which is concerning for thrombocytopenia. Given the risk of severe hemorrhage, the decision is made to prepare the patient for a potential cesarean hysterectomy. The anesthesiology team is consulted to discuss plans for intraoperative management, and the blood bank is alerted to have multiple units of packed red blood cells and fresh frozen plasma on standby.

As the team coordinates care, the patient and her partner are informed about the severity of the situation, including the risks of surgery and the potential for increased maternal morbidity. They are counseled about the necessity of the surgical intervention to ensure the safety of both the mother and the baby. As the patient is prepped for surgery, she begins to exhibit signs of increased anxiety, and the healthcare team provides support and reassurance. The clinical picture necessitates close monitoring and rapid response as the situation continues to evolve.

Section 2

As the surgical team prepares for the operation, the patient's condition continues to evolve with new complications. Just before the procedure, the patient experiences a sudden increase in vaginal bleeding, prompting an immediate reassessment by the healthcare team. Her blood pressure has further declined to 110/70 mmHg, and her heart rate has escalated to 135 bpm, indicating worsening hemodynamic instability. The patient's level of consciousness is slightly altered; she appears drowsy and struggles to stay awake, a concerning sign of diminished cerebral perfusion. Her oxygen saturation drops to 92%, necessitating supplemental oxygen to maintain adequate levels.

In response to these changes, the decision is made to administer an initial bolus of intravenous crystalloids to support her circulatory volume while expediting blood transfusion preparations. The anesthesiology team quickly evaluates the patient for any additional risks associated with anesthesia, considering the potential for hemorrhagic shock. They discuss the plan to use general anesthesia due to the urgency and complexity of the situation, emphasizing the need for close hemodynamic monitoring throughout the procedure.

The increased bleeding and unstable vital signs underscore the urgency of the surgical intervention. The surgical team is briefed on the need for a swift yet careful approach to manage the placental accreta and minimize further blood loss. As the patient is wheeled into the operating room, the team remains vigilant, ready to implement massive transfusion protocols if required. The gravity of the situation is clear, yet the coordinated efforts of the multidisciplinary team aim to ensure the best possible outcome for both the patient and her unborn child.

Section 3

As the operation begins, the surgical team is met with immediate challenges. Upon opening the uterine cavity, the extent of the placental accreta is more severe than initially anticipated. The placenta is deeply embedded into the myometrium, with areas of suspected percreta extending into the bladder wall. This discovery heightens the risk of significant hemorrhage, prompting the team to initiate the massive transfusion protocol. Concurrently, the laboratory results from the blood draw prior to surgery return, indicating a hemoglobin level of 7.2 g/dL and a platelet count of 75,000/mm³, further complicating the patient's ability to clot effectively.

The anesthesiology team remains focused on maintaining hemodynamic stability. Despite the administration of crystalloids, the patient's blood pressure fluctuates between 90/60 mmHg and 100/70 mmHg, while her heart rate remains elevated at 140 bpm. Continuous arterial blood gas monitoring reveals a metabolic acidosis with a pH of 7.28, suggesting ongoing tissue hypoperfusion. In response, the decision is made to administer vasopressors to support her blood pressure, in addition to transfusing packed red blood cells and fresh frozen plasma to address the coagulopathy.

As the procedure progresses, the surgical team employs meticulous techniques to control bleeding, including the use of hemostatic agents and uterine artery ligation. Despite these efforts, the patient's oxygen saturation dips to 88%, necessitating increased ventilatory support. The team recognizes the precarious balance between managing the accreta and preventing further decompensation. This pivotal moment requires critical clinical reasoning to prioritize interventions that stabilize the patient while minimizing additional interventions that could exacerbate her condition. The healthcare team remains united in their goal to navigate these complexities and deliver the best possible outcome for their patient.

Section 4

As the surgical team continues to manage the complex situation, a new complication emerges. The patient's oxygen saturation remains concerningly low despite increased ventilatory support, and her respiratory rate has risen to 30 breaths per minute. This prompts a reassessment of her pulmonary status, revealing decreased breath sounds on the right side. A chest X-ray is immediately ordered and results confirm the presence of a right-sided pleural effusion, likely secondary to fluid overload and capillary leak syndrome associated with the massive transfusion protocol and ongoing resuscitative efforts.

This new development necessitates a shift in the team's focus. The decision is made to perform a therapeutic thoracentesis to relieve the pressure on the right lung and improve oxygenation. The procedure is executed with precision, and 500 mL of serous fluid is aspirated, leading to an immediate improvement in the patient's oxygen saturation, which rises to 94%. Her breath sounds also improve, and her respiratory rate decreases to 22 breaths per minute, providing a momentary stabilization of her respiratory status.

While the immediate respiratory concerns are addressed, the team remains vigilant for other potential complications. The patient's metabolic acidosis continues to be closely monitored, with repeat arterial blood gas analysis showing a pH of 7.32, indicating slight improvement. Despite these efforts, her hemodynamic status remains tenuous, with a blood pressure of 95/65 mmHg and heart rate of 130 bpm. The team deliberates on the next steps, considering the possibility of further complications such as disseminated intravascular coagulation (DIC) due to the underlying coagulopathy and massive transfusion. This requires careful balancing of ongoing interventions while planning for potential additional support measures, such as the administration of cryoprecipitate or further surgical interventions, to ensure the patient's continued stabilization.

Section 5

As the team continues to monitor the patient, a new complication arises that prompts immediate attention. The patient develops increasing abdominal distension and tenderness, raising concerns about potential intra-abdominal bleeding or bowel compromise secondary to the ongoing challenges with placental accreta and recent surgical interventions. An urgent abdominal ultrasound is performed, revealing free fluid in the abdominal cavity, consistent with hemoperitoneum. This finding suggests that despite previous surgical efforts, there may be ongoing bleeding, likely exacerbated by the coagulopathy and massive transfusion.

In response to this development, the team quickly assesses the need for further surgical intervention versus conservative management. The patient's hemoglobin level has dropped to 7.8 g/dL, and her coagulation profile reveals a prolonged prothrombin time (PT) of 18 seconds and a decreased fibrinogen level of 150 mg/dL, supporting the suspicion of disseminated intravascular coagulation (DIC). Given these findings, the decision is made to administer cryoprecipitate to address the fibrinogen deficiency and help stabilize her coagulation status while simultaneously preparing for potential re-exploration in the operating room if the patient's condition does not stabilize.

As the cryoprecipitate infusion begins, the team continues to closely monitor the patient's vital signs and laboratory values. Her blood pressure remains at 90/60 mmHg, and heart rate is 125 bpm, indicating ongoing hemodynamic instability. The infusion leads to a gradual improvement in her fibrinogen levels, rising to 200 mg/dL, which provides some reassurance of her coagulation status stabilizing. However, the team remains on high alert for any further changes in her condition, ready to escalate care as needed. This situation underscores the importance of dynamic clinical reasoning in the face of evolving complications, balancing the need for aggressive intervention with supportive measures to optimize patient outcomes.